| ImClone Systems and Bristol-Myers Squibb Update the Status of Non-Small Cell Lung Cancer Supplemental Biologics ... (Business Wire via Yahoo! Finance) |
|
|
NEW YORK----ImClone Systems, a wholly-owned subsidiary of Eli Lilly and Company , and Bristol-Myers Squibb Company today announced that the companies have decided, after discussion with the U.S. |